Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced entry into its first Covid-19 antibody testing kits supply agreement with law firm McIntyre Thanasides Bringgold Elliott Grimaldi Guito & Matthews, P.A. According to the update, the midsized Tampa firm will today begin periodic testing of its employees and their families, and the partnership will promote a safer working environment and increase Covid-19 exposure risk awareness. Trxade’s Integra Pharma Solutions, LLC subsidiary will provide antibody rapid blood test kits, intended to be administered at point of care with no additional instrumentation needed, and Accomplished Home Health Care staff will perform the testing. “As we start bringing more employees back to the office, we believe that it is important to take additional precautions to protect them. Trxade offers a relatively inexpensive supply solution that delivers quick results. Accomplished Home Health Care provides the medical supervision to ensure that the tests and results are being used appropriately,” the law firm’s President Richard J. McIntyre said in the news release. “We are very grateful to have both of them as partners in this battle against the coronavirus.”
To view the full press release, visit http://ibn.fm/ALKAg
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASQAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual Wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same day or mail order pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
